Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gastrointestinal disorders in Parkinson’s disease and other Lewy body diseases
Masaaki Hirayama, Hiroshi Nishiwaki, Tomonari Hamaguchi, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study
Dong Ji, Wen-Zhu Chen, Lei Zhang, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 46
Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration
Nasir Uddin Mahbub, Md Minarul Islam, Seong‐Tshool Hong, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 12
The Role of the Gut Microbiota in Neurodegenerative Diseases
Arshilin Philip Mani, Balamuralikrishnan Balasubramanian, Linsha A. Mali, et al.
Microbiology Research (2024) Vol. 15, Iss. 2, pp. 489-507
Open Access | Times Cited: 10
Meta-analysis of shotgun sequencing of gut microbiota in Parkinson’s disease
Hiroshi Nishiwaki, Jun Ueyama, Mikako Ito, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
The molecular interplay between human and bacterial amyloids: Implications in neurodegenerative diseases
Neha Jain
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2024) Vol. 1872, Iss. 4, pp. 141018-141018
Closed Access | Times Cited: 5
Detection of hypochlorous acid fluctuation via a near-infrared fluorescent probe in Parkinson’s disease cells and mouse models
Xumei Wang, Ke Wu, Ruixin Liu, et al.
Methods (2025)
Closed Access
The Intricate Interplay: Microbial Metabolites and the Gut‐Liver‐Brain Axis in Parkinson's Disease
Dayamrita Kollaparampil Kishanchand, Athira Krishnan K. A., Krishnapriya Chandrababu, et al.
Journal of Neuroscience Research (2025) Vol. 103, Iss. 1
Closed Access
Protective effect of ginsenoside CK against MPTP-induced Parkinson’ s disease mouse model by suppressing oxidative stress and inflammation, and modulating the gut microbiota
Yang Xu, Yuting Zhao, Lily Liang, et al.
Microbial Pathogenesis (2025), pp. 107409-107409
Closed Access
Microbial metabolite 3-indolepropionic acid alleviated PD pathologies by decreasing enteric glia cell gliosis via suppressing IL-13Rα1 related signaling pathways
Meiyu Shang, Jingwen Ning, Caixia Zang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Probiotics as Potential Treatments for Neurodegenerative Diseases: a Review of the Evidence from in vivo to Clinical Trial
Jin Hee Kim, Yujin Choi, Seung-Min Lee, et al.
Biomolecules & Therapeutics (2024)
Open Access | Times Cited: 2
Diagnostic accuracy and predictors of alpha-synuclein accumulation in the gastrointestinal tract of Parkinson’s disease
Chaewon Shin, Seong‐Ik Kim, Sung‐Hye Park, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Neuroprotective effects of biogenic silver nanoparticles in Parkinson's disease: In vitro and in vivo study
Siren Zhao, Jilun Zhang, Jianbin Zhang
International Journal of Biological Macromolecules (2024), pp. 138236-138236
Open Access | Times Cited: 1
Oral and gut microbiome profiles in early Parkinson’s disease
Keaton Stagaman, Matthew Kmiecik, Madeleine Wetzel, et al.
Research Square (Research Square) (2024)
Open Access
Mogroside V and mogrol: unveiling the neuroprotective and metabolic regulatory roles of Siraitia grosvenorii in Parkinson’s disease
Quan Tang, Rui Qiu, Mei Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
An in vitro multi-organ microphysiological system (MPS) to investigate the gut-to-brain translocation of neurotoxins
Emily Jones, Benjamin M. Skinner, Aimée Parker, et al.
Biomicrofluidics (2024) Vol. 18, Iss. 5
Closed Access
Oral and gut microbiome profiles in people with early idiopathic Parkinson’s disease
Keaton Stagaman, Matthew J. Kmiecik, Madeleine Wetzel, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access
The Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Various Neurocognitive Disorders
Zainab A Castro-Vidal, Febina M. Mathew, Abdelrahman Ezzat, et al.
Cureus (2024)
Open Access
Smoking, coffee intake, and Parkinson’s disease: potential protective mechanisms and components
Sa Weon Hong, Rachel Page, Penelope Truman
NeuroToxicology (2024)
Open Access
Depression in Parkinson’s Disease: A Trajectory Linking Gut Microbiota and Neuroinflammation
Punit Prasanna Kujur, Manas Ranjan Sahu, Amal Chandra Mondal
Integrated science (2024), pp. 323-355
Closed Access
Bibliometric analysis of global research trends on regulatory T cells in neurological diseases
Qian Gao, Xinmin Li, Yan Li, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 1
Page 1

Scroll to top